Figure 2. Showing publications on AI in breast cancer diagnosis between 2012–2022. Table 2. Various algorithms of AI applications and performances in breast cancer diagnosis. In addition, Table 3 shows the comparison of the latest related studies. However, accuracy (99%) has the highest numb...
This dominant market share is attributable to several factors such as the high incidence of breast cancer, steadily rising disease burden, and presence of major market players among others. According to the Breast Cancer Organizations statistics, as of January 2022, breast cancer affects more than ...
Mechanisms driving the immunoregulatory function of cancer cells Article 30 January 2023 TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective Article 15 November 2022 References Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, ...
To investigate the biological function of circPSMA1 in breast cancer cells, loss-of-function and gain-of-function assays were performed. The qRT-PCR results showed the circPSMA1 overexpression or knockdown efficiency of transfection with the circPSMA1 overexpression or RNAi vector (Fig. 2A, B);...
2022. Accessed March 26, 2024. https://seer.cancer.gov/data-software/documentation/seerstat/nov2021/ 4. Henderson JT, Webber EM, Weyrich M, Miller M, Melnikow J. Screening for Breast Cancer: A Comparative Effectiveness Review for the US Preventive Services Task Force. ...
Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23. PubMed PMID: 36084384; PMCID: PMC9465273. Article PubMed PubMed Central Google Scholar Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-...
1B. The ΔSPC of the breast cancer surgery rate was 2.7% pre-pandemic and 2.5% in the total time series. Furthermore, between 2014 and 2022, the average annual rate of breast cancer hospitalizations per 10,000 women was 8.12 in the public healthcare system (SD ± 0.51; minimum ...
BMC Cancer. 2022;22. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast: Official J Eur Soc Mastology. 2022;66:15. Article Google Scholar Wagstaff A, Flores G, Hsu J, ...
BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. GeneReviews Initial posting September 4, 1998; updated December 15, 2016. Google Scholar 3 A.G. Knudson Jr. Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci USA, 68 (1971), pp. 820-823 Crossref...
Nature Cancer volume 3, pages 232–250 (2022)Cite this article 55k Accesses 173 Citations 164 Altmetric Metrics details Abstract Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenograft...